09:40 AM EST - Cardiol Therapeutics Inc. : Announced today its year-end 2024 update on operations following the filing of its audited Financial Statements and Management's Discussion and Analysis for the year ended December 31, 2024. Both are available under the Company's profile on EDGAR at www.sec.gov, on SEDAR+ at sedarplus.ca and on the Company's website at cardiolrx.com. Cardiol Therapeutics Inc.
shares T.CRDL are trading unchanged at $1.37.
